134 related articles for article (PubMed ID: 34266344)
21. In Silico design of AVP (4-5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles.
Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; E Ozel A; Akyuz S
Daru; 2020 Jun; 28(1):139-157. PubMed ID: 31942695
[TBL] [Abstract][Full Text] [Related]
22. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
Wang F; Yang S; Yuan J; Gao Q; Huang C
J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Fathi M; Barar J; Erfan-Niya H; Omidi Y
Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
[TBL] [Abstract][Full Text] [Related]
24. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
26. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
[TBL] [Abstract][Full Text] [Related]
27. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
28. Gossypol-Capped Mitoxantrone-Loaded Mesoporous SiO2 NPs for the Cooperative Controlled Release of Two Anti-Cancer Drugs.
Heleg-Shabtai V; Aizen R; Sharon E; Sohn YS; Trifonov A; Enkin N; Freage L; Nechushtai R; Willner I
ACS Appl Mater Interfaces; 2016 Jun; 8(23):14414-22. PubMed ID: 27186957
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films.
Al-Nemrawi NK; Alsharif SSM; Alzoubi KH; Alkhatib RQ
Pharm Dev Technol; 2019 Oct; 24(8):967-974. PubMed ID: 31092092
[TBL] [Abstract][Full Text] [Related]
31. Tobacco mosaic virus delivery of mitoxantrone for cancer therapy.
Lin RD; Steinmetz NF
Nanoscale; 2018 Aug; 10(34):16307-16313. PubMed ID: 30129956
[TBL] [Abstract][Full Text] [Related]
32. Chitosan based copolymer-drug conjugate and its protein targeted polyelectrolyte complex nanoparticles to enhance the efficiency and specificity of low potency anticancer agent.
Sutar YB; Telvekar VN
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():393-406. PubMed ID: 30184765
[TBL] [Abstract][Full Text] [Related]
33. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
[TBL] [Abstract][Full Text] [Related]
34. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
[TBL] [Abstract][Full Text] [Related]
35. Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.
Hornung A; Poettler M; Friedrich RP; Zaloga J; Unterweger H; Lyer S; Nowak J; Odenbach S; Alexiou C; Janko C
Molecules; 2015 Sep; 20(10):18016-30. PubMed ID: 26437393
[TBL] [Abstract][Full Text] [Related]
36. Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin.
Tammam SN; Azzazy HME; Lamprecht A
Eur J Pharm Biopharm; 2018 Aug; 129():74-79. PubMed ID: 29802982
[TBL] [Abstract][Full Text] [Related]
37. Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy.
Qian L; Zheng J; Wang K; Tang Y; Zhang X; Zhang H; Huang F; Pei Y; Jiang Y
Biomaterials; 2013 Nov; 34(35):8968-78. PubMed ID: 23953782
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
39. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
Samprasit W; Opanasopit P; Chamsai B
Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571
[TBL] [Abstract][Full Text] [Related]
40. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
